Contezolid

Contezolid (MRX-I), a new and orally active oxazolidinone, is an antibiotic in study for complicated skin and soft tissue infections (cSSTI) caused by resistant Gram-positive bacteria. Contezolid (MRX-I) markedly reduces potential for myelosuppression and monoamine oxidase inhibition (MAOI).


Cat. No.: EX-A7015	Purity: >98%

	Chemical structure of Contezolid

For research only, Do not use for Human!

Size	Unit Price (US$)	Stock
250mg	850	In-stock
500mg	1300	In-stock
1g	2400	In-stock

Send PO to E-mail:[email protected]; or Fax:+86 020 81619670

Discount Request


Synonyms	MRX-I
CAS No.	1112968-42-9
Purity	>98%
Formula	C18H15F3N4O4
Mol Weight	408.3313
Color	White to light yellow
State	solid powder
Solubility	Soluble in DMSO 120 mg/mL
Shelf Life	>2 years if stored properly
Storage	Powder 4℃, sealed storage, away from moisture and light In solvent : -80℃, 6 months; -20℃, 1 month (sealed storage, away from moisture and light)
Shipping	Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.

Reference:	[1]. Junzhen Wu, et al. Evaluation of the Effect of Contezolid (MRX-I) on the Corrected QT Interval in a Randomized, Double-Blind, Placebo- and Positive-Controlled Crossover Study in Healthy Chinese Volunteers. Antimicrob Agents Chemother. 2020 May 21;64(6):e02158-19. [2]. Mikhail F Gordeev, et al. New potent antibacterial oxazolidinone (MRX-I) with an improved class safety profile. J Med Chem. 2014 Jun 12;57(11):4487-97. [3]. Carolyn Shoen, et al. In Vitro and In Vivo Activities of Contezolid (MRX-I) against Mycobacterium tuberculosis. Antimicrob Agents Chemother. 2018 Jul 27;62(8):e00493-18.
CoA	CoA of Contezolid


		Search